Table 2 The study protocol for each group.
Control | NE | REIA | 3-d AA | 1-week AA | 2-week AA | MTI | |
|---|---|---|---|---|---|---|---|
Fed under normal conditions | Always | 2 weeks | 2 weeks | 11 days | 1 week | No | No |
Fed under altitude conditions | No | No | No | 3 days | 1 week | 2 weeks | 2 weeks |
Inhibitor intraperitoneal injection | No | No | No | No | No | No | Yes |
Treadmill load exercise | No | Yes# | Yes* | Yes* | Yes* | Yes* | Yes* |
Recorded exhaustive timea | No | Yes | Yes | Yes | Yes | Yes | Yes |
Western blottingb | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Immunohistochemical detectionc | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Neuropathological evaluationc | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Brain lactate content determinationd | Yes | Yes | Yes | Yes | Yes | Yes | Yes |